Mark Nuttall

Vice President of Quality Assurance at Rénibus Therapeutics

Mark Nuttall has extensive experience in the Quality Assurance field, having worked in various roles since 1992. Mark began their career at Adams Laboratories as a Laboratory Supervisor, and then moved on to Adams Respiratory Therapeutics in 2004 as Director of Analytical Development. In 2007, they joined Reckitt Benckiser as Analytical Development Manager, and then went on to ZS Pharma, Inc. in 2012 as Vice President of Quality Assurance. After that, they worked at AstraZeneca in the same role from 2015 to 2017, and is currently employed at Rénibus Therapeutics Inc. as Vice President of Quality Assurance.

Mark Nuttall attended The University of Texas at Arlington from 1987 to 1992, where they earned a Bachelor of Science degree in Biology.

Location

Fort Worth, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Rénibus Therapeutics

Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.


Industries

Employees

51-200

Links